NbN3 APK 下载 最新 -  inManage LTD
下载 NbN3 安装 最新 APK 下载程序

NbN3 3.4 APK

3.1/5

最新版本: 3.4
DMCA 的策略 (业主)

得到的最后一个版本 NbN3 App 从 Medical 对于 Android. It has become clear that the current pharmacological nomenclature of psychotropic medications does not reflect our contemporary knowledge, nor does it inform properly the clinician of... 阅读详细信息 >

43 votes, 3.1 stars

NbN3   il.co.inmanage.nbnomenclature   应用程序详细信息

NbN3   屏幕截图

NbN3
NbN3

NbN3   说明

编辑评论

inManage LTD recently released the app NbN3. NbN3 is a Medical app with the user-friendly design by inManage LTD that ensures that all of your controls are always right where you need them.The latest APK version of NbN3 for Android phones and tablets is 3.4 compatible with 2019 models like Google Pixel 3, OnePlus 6T, LG G7 ThinQ. This app best serves on the releases Samsung Galaxy S9 and Galaxy Note 9, LG G6, Motorola Moto X4, Google Nexus, and TCL BlackBerry Key2 mobile phones and android devices having system version 4.2 and higher. The last app NbN3 mod was distributed on 11-1月-2022 and has google play package name il.co.inmanage.nbnomenclature. Easy and fast android APK download of NbN3 version 3.4 is available directly on ApkStore.top repository. NbN3 APK file and trademarks are the property of the developer inManage LTD. Please note that we only provide the original and free apk package installation without any modifications linked from the official sources. Check our "safe download" sign to get the latest report from McAfee security check to see if the NbN3 app download is completely secure. Users who installed and used this app liked over 43 user votes with a total rating 3.0 of 5 stars towards NbN3 ranking. More than 10000 players gave their attention to this app so far. You can freely download NbN3 app APK and OBB files directly on our ApkStore.top safe play market!


说明


下载并安装 免费 android apk 文件 对于 NbN3.

      最新版本点评 NbN3

      版本历史记录

    NbN3 3.4

    2022-01-11
    新增功能: NbN3 apk bug fixes and app improvements. New download for NbN3 apk file.

    新增功能

    COMMENTS